Akero Therapeutics Inc (AKRO)
29.34
+0.94
(+3.31%)
USD |
NASDAQ |
Dec 20, 16:00
27.51
-1.83
(-6.24%)
After-Hours: 04:41
Akero Therapeutics Shareholders Equity (Quarterly): 738.32M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 777.16M |
| 89bio Inc | 378.10M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 817.55M |
| Total Liabilities (Quarterly) | 79.22M |